Basic Search
|
Geographic Searches
|
Advanced Search |
Megadeals
Subsidy Tracker Parent Company Summary
Parent Company Name: Roche
Ownership Structure: publicly traded
Headquartered in: Switzerland
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
| Subsidy Summary | Subsidy Value | Number of Awards |
| State/Local | $22,259,078 | 33 |
| Federal (grants and allocated tax credits) | $2,855,915 | 10 |
| TOTAL | $25,114,993 | 43 |
| Loan / Bailout Summary | Total Face Value | Number of Awards |
| State/Local loans, bond financing and venture capital | $0 | 0 |
| Federal loans, loan guarantees and bailout assistance (not including repayments) | $0 | 0 |
| TOTAL | $0 | 0 |
Time Period for State and Local Awards: Earliest year of data: 2000. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2011.
Time Period for Federal Awards: FY2000 to the present
Notes: Dollar totals do not include awards for which no subsidy value is disclosed.
Links: For a summary of this company's regulatory violations see its Violation Tracker summary page
here.
| Top 5 States for state/local awards | Total Subsidy $ | Number of Awards |
| Oregon | $7,385,371 | 3 |
| Pennsylvania | $5,350,896 | 14 |
| Indiana | $2,570,000 | 5 |
| Kentucky | $2,400,000 | 1 |
| Massachusetts | $1,754,946 | 4 |
| All other | $2,797,865 | 6 |
Individual Subsidy Records:
Click on the company name for more information on each subsidy award.
| Company | Location | Subsidy Source | Year  . | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
| GENENTECH INC | United States | federal | 2022 | $768,098 | | federal grant |
| GENENTECH, INC. | United States | federal | 2021 | $507,341 | | federal grant |
| GENENTECH, INC. | United States | federal | 2020 | $251,057 | | federal grant |
| SPARK THERAPEUTICS, LLC | Pennsylvania | state | 2020 | $1,687,300 | | tax credit/rebate |
| VENTANA USA | Pennsylvania | state | 2020 | $4,200 | | tax credit/rebate |
| Spark Therapeutics, Inc. | Pennsylvania | state | 2019 | $2,000,000 | | grant |
| Spark Therapeutics, LLC | Pennsylvania | state | 2017 | $790,740 | | tax credit/rebate |
| Foundation Medicine | Massachusetts | state | 2014 | $1,225,860 | | tax credit/rebate |
| Spark Therapeutics Inc | Pennsylvania | state | 2014 | $201,000 | | tax credit/rebate |
| Spark Therapeutics Inc | Pennsylvania | state | 2014 | $150,000 | | grant |
| Genentech Inc | Oregon | state | 2013 | $3,340,842 | | tax credit/rebate |
| Genentech | Oregon | state | 2013 | $227,332 | | property tax abatement |
| Foundation Medicine, Inc. | Massachusetts | state | 2013 | $150,000 | | tax credit/rebate |
| Foundation Medicine, Inc. | Massachusetts | state | 2013 | $300,309 | | tax credit/rebate |
| Ventana USA | Pennsylvania | state | 2013 | $12,320 | | tax credit/rebate |
| Genentech USA Inc. | Oregon | state | 2012 | $3,817,197 | | property tax abatement |
| Ventana USA, LLP | Pennsylvania | state | 2012 | $28,896 | | tax credit/rebate |
| Roche Diagnostics Operations, Inc. | Indiana | state | 2012 | $2,000,000 | | tax credit/rebate |
| Roche Diagnostics Operations, Inc. | Indiana | state | 2012 | $300,000 | | training reimbursement |
| Foundation Medicine Inc. | Massachusetts | state | 2011 | $78,777 | | tax credit/rebate |
| Ventana USA, LLP | Pennsylvania | state | 2011 | $55,480 | | tax credit/rebate |
| Ventana USA, LLP | Pennsylvania | state | 2010 | $16,124 | | tax credit/rebate |
| Roche Diagnostics Operations, Inc. | Indiana | state | 2010 | $50,000 | | training reimbursement |
| Roche Carolina Inc. | South Carolina | state | 2009 | undisclosed | | tax credit/rebate |
| Roche Diagnostics Operations, Inc. | Indiana | state | 2008 | $200,000 | | training reimbursement |
| GENENTECH, INC. | California | state | 2007 | $602,758 | | training reimbursement |
| Ventana Medical Systems, Inc. | Arizona | state | 2007 | $129,073 | | training reimbursement |
| Ventana Medical Systems, Inc. | Arizona | state | 2007 | $454,796 | | training reimbursement |
| ROCHE DIAGNOSTICS/ROCHE APPLIED SCIENCE | United States | federal | 2007 | $42,975 | | federal grant |
| Genentech USA, Inc. | Kentucky | state | 2006 | $2,400,000 | | tax credit/rebate |
| Roche Carolina, Inc. | South Carolina | state | 2006 | undisclosed | | tax credit/rebate |
| Ventana Medical Systems, Inc. | Arizona | state | 2005 | $443,248 | | training reimbursement |
| Disetronic Medical Systems, Incorporated | Indiana | state | 2005 | $20,000 | | training reimbursement |
| Chugai Pharma USA | New Jersey | state | 2004 | $582,225 | | grant |
| Ventana Medical Systems | Arizona | state | 2003 | $585,765 | | training reimbursement |
| SYNTEX USA, LLC | United States | federal | 2002 | $309,327 | | federal grant |
| SYNTEX USA, LLC | United States | federal | 2002 | $61,000 | | federal grant |
| SYNTEX USA, LLC | United States | federal | 2001 | $297,793 | | federal grant |
| SYNTEX USA, LLC | United States | federal | 2001 | $121,136 | | federal grant |
| INTERMUNE PHARMACEUTICALS INC | United States | federal | 2001 | $100,000 | | federal grant |
| SYNTEX USA, LLC | United States | federal | 2000 | $397,188 | | federal grant |
| Ventana USA | Pennsylvania | state | | $28,836 | | training reimbursement |
| Ventana USA | Pennsylvania | state | | $25,000 | | tax credit/rebate |
| Spark Therapeutics Inc | Pennsylvania | state | | $150,000 | | grant |
| Spark Therapeutics Inc | Pennsylvania | state | | $201,000 | | tax credit/rebate |
